Sarepta Therapeutics
SRPT
#1385
Rank
$12.03 B
Marketcap
$127.39
Share price
2.53%
Change (1 day)
3.32%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Cash on Hand

Cash on Hand as of December 2023 : $1.67 B

According to Sarepta Therapeutics 's latest financial reports the company has $1.67 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sarepta Therapeutics - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$1.67 B-15.74%
2022-12-31$1.98 B-5.98%
2021-12-31$2.11 B9.15%
2020-12-31$1.93 B72.36%
2019-12-31$1.12 B-4.19%
2018-12-31$1.17 B8.79%
2017-12-31$1.07 B239.49%
2016-12-31$0.31 B65.12%
2015-12-31$0.19 B-8.49%
2014-12-31$0.21 B-18.14%
2013-12-31$0.25 B36.93%
2012-12-31$0.18 B370.28%
2011-12-31$39.9 M18.8%
2010-12-31$33.58 M-30.42%
2009-12-31$48.27 M320.73%
2008-12-31$11.47 M-54.24%
2007-12-31$25.07 M-24.37%
2006-12-31$33.15 M-29.54%
2005-12-31$47.05 M141.1%
2004-12-31$19.51 M-48.1%
2003-12-31$37.59 M94.88%
2002-12-31$19.29 M-24.63%
2001-12-31$25.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$7.26 B 333.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.87 B-47.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.56 B-66.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.43 B 45.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.78 B-53.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38 B-76.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.59 B-64.48%๐Ÿ‡บ๐Ÿ‡ธ USA